Increased Adoption of qPCR Technology Solutions Will to Drive High Growth in the Global Polymerase Chain Reaction Market: Technavio

Renewable energy

 

According to the latest market research study released by Technavio, the global polymerase chain reaction market is expected to grow at a CAGR of more than 8% during the forecast period 2016-2020.

This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.

Click here to request a free sample of this report

Technavio research analysts categorize the global polymerase chain reaction market based on technology:

Global polymerase chain reaction market share by technology 2015

qPCR

44.13%

Standard PCR

34.18%

dPCR

21.69%

                                                                    Source: Technavio

Global qPCR market

The global polymerase chain reaction market qPCR technology was valued at more than $4 billion in 2015 and will grow at a CAGR of around 8% by 2020. The increasing adopting qPCR technology solutions in applications like genotyping, quantitative gene expression analysis, and drug target validation will lead to the growth of this market segment. This solution has a dynamic range of detection and collection of data from the exponential growth phase and has an ability to carry out sensitive gene analysis. The applications of these solutions include genotyping, single-nucleotide polymorphism analysis, quantitative gene expression analysis, drug target validation, pathogen detection, and measuring RNA interference.

The increased application of qPCR solutions in robotics will grow during the forecast period. These solutions increase the speed of the lab automation process, helps in decreasing total project time by eliminating bottlenecks, technical glitches, and cutting down delays. These solutions enables automation of workflow and the ability to provide greater reproducibility and precision,” says Vishnu Vel R, a lead analyst at Technavio for research on lab equipment.

Global standard PCR market

The global polymerase chain reaction market by standard PCR technology was valued at around $3 billion in 2015 and will grow at a CAGR of more than 7% by 2020. The increased application of standard PCR solutions in amplification of DNA for genotyping, sequencing, and cloning will one of the major drivers for this market segment. Standard PCR solutions have the ability to rapidly identify the parasites which traditional diagnostic tools like serological and parasitological does not provide. The standard PCR solutions including devices and consumables are priced effectively which enables smaller laboratories to use these methods for testing.

Global dPCR market

The global polymerase chain reaction market by dPCR technology was valued at about $2 billion in 2015 and will grow at a CAGR of more than 10% by 2020. The dPCR solutions are extensively used for validating next-generation sequencing experiments, rare allele detection, and for determining fine copy number variances. The advantages of these solutions like real-time process monitoring and low reagent consumption to conduct testing will help in the growth of this market segment. Pharmaceutical organizations, biotechnology companies and research institutes prefer using these solutions over PCR technology. These solutions provides extremely high sensitivity and quantification of the target nucleic acids by partition samples through microfluidic chips, channels, or droplets.

The top leading vendors operating in the global polymerase chain reaction market are:

  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche Diagnostics
  • Thermo Fisher Scientific

Other prominent vendors in the market include Beckman Coulter, Becton, Dickinson and Company, bioMérieux, Cepheid, Takara Bio, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, RainDance Technologies, and Siemens Healthcare.

A more detailed analysis is available in the Technavio report titled, ‘Global Polymerase Chain Reaction Market 2016-2020’. Technavio also customizes reports by other regions and specific segments upon request.

Other related reports:

To read more press releases- click here.

For any assistance or query, please contact our media team at:

media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com